Ian S Westley

980 total citations
23 papers, 759 citations indexed

About

Ian S Westley is a scholar working on Transplantation, Infectious Diseases and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Ian S Westley has authored 23 papers receiving a total of 759 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Transplantation, 8 papers in Infectious Diseases and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Ian S Westley's work include Renal Transplantation Outcomes and Treatments (10 papers), Pharmacological Effects and Toxicity Studies (7 papers) and HIV/AIDS drug development and treatment (6 papers). Ian S Westley is often cited by papers focused on Renal Transplantation Outcomes and Treatments (10 papers), Pharmacological Effects and Toxicity Studies (7 papers) and HIV/AIDS drug development and treatment (6 papers). Ian S Westley collaborates with scholars based in Australia, United Kingdom and Belgium. Ian S Westley's co-authors include Raymond G. Morris, Benedetta C. Sallustio, N. Undre, A. E. Johnston, Vincent Haufroid, Merçè Brunet, Pierre Marquet, Michael Oellerich, Éric Thervet and Michel Mourad and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Clinical Chemistry.

In The Last Decade

Ian S Westley

23 papers receiving 749 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ian S Westley Australia 12 521 378 163 153 141 23 759
N. Undre United Kingdom 7 581 1.1× 417 1.1× 180 1.1× 111 0.7× 131 0.9× 11 688
Louise M. Andrews Netherlands 14 462 0.9× 313 0.8× 154 0.9× 110 0.7× 118 0.8× 24 654
Sheila Zuckerman United States 7 735 1.4× 430 1.1× 265 1.6× 146 1.0× 166 1.2× 11 963
A.-É. Heng France 9 504 1.0× 263 0.7× 193 1.2× 104 0.7× 75 0.5× 18 661
Nils Tore Vethe Norway 16 370 0.7× 135 0.4× 164 1.0× 72 0.5× 70 0.5× 59 678
Elisabet Størset Norway 10 315 0.6× 211 0.6× 122 0.7× 76 0.5× 76 0.5× 20 434
Azemi Barama Canada 14 351 0.7× 190 0.5× 126 0.8× 61 0.4× 66 0.5× 28 672
Djamila Chaïb Eddour Belgium 12 1.0k 1.9× 685 1.8× 202 1.2× 190 1.2× 227 1.6× 14 1.2k
Ilse P. van der Heiden Netherlands 12 338 0.6× 409 1.1× 113 0.7× 43 0.3× 117 0.8× 17 888
Andy Nicholls United Kingdom 8 561 1.1× 149 0.4× 129 0.8× 236 1.5× 85 0.6× 11 778

Countries citing papers authored by Ian S Westley

Since Specialization
Citations

This map shows the geographic impact of Ian S Westley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian S Westley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian S Westley more than expected).

Fields of papers citing papers by Ian S Westley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian S Westley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian S Westley. The network helps show where Ian S Westley may publish in the future.

Co-authorship network of co-authors of Ian S Westley

This figure shows the co-authorship network connecting the top 25 collaborators of Ian S Westley. A scholar is included among the top collaborators of Ian S Westley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian S Westley. Ian S Westley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heffernan, Aaron J., David T Yeung, Morgyn S. Warner, et al.. (2024). Population pharmacokinetics of posaconazole in allogeneic haematopoietic stem cell transplant patients. Journal of Antimicrobial Chemotherapy. 79(3). 567–577. 3 indexed citations
2.
Baranoff, John, R. Louise Rushworth, Ian S Westley, et al.. (2022). The effect of cognitive behavioral stress management on perceived stress, biological stress markers and weight loss/regain, from a diet-induced weight loss program: A randomized controlled trial. SHILAP Revista de lepidopterología. 10. 100124–100124. 2 indexed citations
3.
4.
Westley, Ian S, et al.. (2022). Consistency of remifentanil concentrations in propofol–Remifentanil infusions. A laboratory‐based study. Pediatric Anesthesia. 32(6). 727–731. 4 indexed citations
5.
Flanagan, Emma, Emily K. Wright, Winita Hardikar, et al.. (2021). Maternal thiopurine metabolism during pregnancy in inflammatory bowel disease and clearance of thiopurine metabolites and outcomes in exposed neonates. Alimentary Pharmacology & Therapeutics. 53(7). 810–820. 22 indexed citations
6.
7.
Morris, Raymond G., et al.. (2014). Ropivacaine (Total and Unbound) and AGP Concentrations After Transversus Abdominis Plane Block for Analgesia After Abdominal Surgery. Therapeutic Drug Monitoring. 36(6). 759–764. 11 indexed citations
8.
9.
Westley, Ian S, et al.. (2013). Interaction of Terbinafine (Anti-fungal agent) with Perhexiline: A Case Report. Heart Lung and Circulation. 23(6). e149–e151. 7 indexed citations
10.
Wallemacq, Pierre, Victor W. Armstrong, Merçè Brunet, et al.. (2009). Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference. Therapeutic Drug Monitoring. 31(2). 139–152. 362 indexed citations
11.
Westley, Ian S & Raymond G. Morris. (2008). Seradyn Quantitative Microsphere System Lamotrigine Immunoassay on a Hitachi 911 Analyzer Compared With HPLC-UV. Therapeutic Drug Monitoring. 30(5). 634–637. 15 indexed citations
12.
Westley, Ian S, Paul J. Taylor, Paul Salm, & Raymond G. Morris. (2007). Cloned Enzyme Donor Immunoassay Tacrolimus Assay Compared With High-Performance Liquid Chromatography-Tandem Mass Spectrometry and Microparticle Enzyme Immunoassay in Liver and Renal Transplant Recipients. Therapeutic Drug Monitoring. 29(5). 584–591. 23 indexed citations
13.
Westley, Ian S, Raymond G. Morris, Allan M. Evans, & Benedetta C. Sallustio. (2007). Glucuronidation of Mycophenolic Acid by Wistar and Mrp2-Deficient TR- Rat Liver Microsomes. Drug Metabolism and Disposition. 36(1). 46–50. 7 indexed citations
14.
Westley, Ian S, John E. Ray, & Raymond G. Morris. (2006). CEDIA® Mycophenolic Acid Assay Compared With HPLC-UV in Specimens From Transplant Recipients. Therapeutic Drug Monitoring. 28(5). 632–636. 19 indexed citations
15.
Westley, Ian S, et al.. (2005). ROLE OF MRP2 IN THE HEPATIC DISPOSITION OF MYCOPHENOLIC ACID AND ITS GLUCURONIDE METABOLITES: EFFECT OF CYCLOSPORINE. Drug Metabolism and Disposition. 34(2). 261–266. 90 indexed citations
16.
Westley, Ian S, Benedetta C. Sallustio, & Raymond G. Morris. (2005). Validation of a high-performance liquid chromatography method for the measurement of mycophenolic acid and its glucuronide metabolites in plasma. Clinical Biochemistry. 38(9). 824–829. 37 indexed citations
17.
Westley, Ian S, et al.. (2005). CEDIA® Sirolimus Assay Compared With HPLC-MS/MS and HPLC-UV in Transplant Recipient Specimens. Therapeutic Drug Monitoring. 27(3). 309–314. 8 indexed citations
18.
Sallustio, Benedetta C., Ian S Westley, & Raymond G. Morris. (2002). Pharmacokinetics of the antianginal agent perhexiline: relationship between metabolic ratio and steady‐state dose. British Journal of Clinical Pharmacology. 54(2). 107–114. 46 indexed citations
19.
Morris, Raymond G., et al.. (2000). Clinical Study of Lamotrigine and Valproic Acid in Patients With Epilepsy: Using a Drug Interaction to Advantage?. Therapeutic Drug Monitoring. 22(6). 656–660. 35 indexed citations
20.
Morris, Richard, et al.. (1999). TIME COURSE OF THE INHIBITION OF CYCLOSPORIN OR TACROLIMUS METABOLISM BY DILTIAZEM.. Therapeutic Drug Monitoring. 21(4). 437–437. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by N. Undre Breakdown of academic impact, for papers by Louise M. Andrews Breakdown of academic impact, for papers by Sheila Zuckerman Breakdown of academic impact, for papers by A.-É. Heng Breakdown of academic impact, for papers by Nils Tore Vethe Breakdown of academic impact, for papers by Elisabet Størset Breakdown of academic impact, for papers by Azemi Barama Breakdown of academic impact, for papers by Djamila Chaïb Eddour Breakdown of academic impact, for papers by Ilse P. van der Heiden Breakdown of academic impact, for papers by Andy Nicholls
Rankless by CCL
2026